| Literature DB >> 30732567 |
Shiqiang Xu1, Jihua Wang1,2, Haixuan Wang1, Yixue Bao1, Yisha Li1, Muralidharan Govindaraju1, Wei Yao1, Baoshan Chen1, Muqing Zhang3.
Abstract
BACKGROUND: Pokkah boeng is one of the most serious and devastating diseases of sugarcane and causes significant loss in cane yield and sugar content. Although carbendazim is widely used to prevent fungal diseases, the molecular basis of Fusarium species complex (FSC) resistance to carbendazim remains unknown.Entities:
Keywords: Carbendazim-induced mutant; Fusarium proliferatum; Fusarium verticillioides; Gene expression profile; Pokkah boeng
Mesh:
Substances:
Year: 2019 PMID: 30732567 PMCID: PMC6367828 DOI: 10.1186/s12864-019-5479-6
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Frequency distribution of EC50 values to carbendazim for 35 FSC isolates. The isolates were recovered from major sugarcane production areas of China and the sensitivity curve was normally distributed over a sensitive range
Fig. 2Colony morphology of FSC wild types and their mutants. (a) The fan-shaped region on the edge of the colony induced by carbendazim of SJ51 (on day 5) and HC30 (on day 8); (b) Mycelial growth of two FSC strains and their resistant mutants exposed to carbendazim. All strains were grown at 28 °C for 3 days on PDA media amended with carbendazim at 0, 0.7, 0.9, 1.1, 1.5 or 2.0 μg a.i.mL− 1
Number of DEGs in SJ51M and its corresponding wild type strain SJ51
| DEG Set | All DEGs | Up-regulated DEGs | Down-regulated DEGs |
|---|---|---|---|
| SJ51_E vs SJ51_C | 183 | 135 | 48 |
| SJ51M_E vs SJ51M_C | 290 | 225 | 65 |
| SJ51M_C vs SJ51_C | 350 | 183 | 167 |
| SJ51M_E vs SJ51_E | 456 | 278 | 178 |
SJ51_C and SJ51M_C represented without carbendazim treatment, while SJ51_E and SJ51M_E represented exposed to carbendazim treatment. The cut-off limit of DEGs was less than 0.05 FDR and greater than 2-fold change
Fig. 3Venn diagrams showing the number of DEGs in SJ51M and its corresponding wild type strain SJ51. (a) The number of unique and shared DEGs of SJ51M and SJ51 responding to carbendazim treatment; (b) The number of unique and shared DEGs between SJ51M and SJ51 with and without carbendazim treatment. SJ51_C and SJ51M_C represented without carbendazim treatment, while SJ51_E and SJ51M_E represented exposed to carbendazim treatment. The cut-off limit of DEGs was less than 0.05 FDR and greater than 2-fold change
Fig. 4Heatmaps showing the expression pattern of DEGs. The expression pattern of DEGs related to transmembrane transport (GO:0055085) (a) and response to stress (GO:0006950) (b). SJ51_C and SJ51M_C represented without carbendazim treatment, while SJ51_E and SJ51M_E represented exposed to carbendazim treatment. Color scale showing the level of gene expression of log2 (FPKM+ 1). The cut-off limit of DEGs was less than 0.05 FDR and greater than 2-fold change
Fig. 5Hierarchical clustering showing the expression of carbendazim-induced DEGs. Gene expression pattern for 850 DEGs clustering into twelve clusters (a) and distribution of gene expression values with similar modulation in clusters I (b), II (c), III (d), IX (e) and X (f) which showed the increased expression in SJ51M_E compared with SJ51 after exposure to carbendazim. SJ51_C and SJ51M_C represented without carbendazim treatment, while SJ51_E and SJ51M_E represented exposed to carbendazim treatment. Color scale showed the level of gene expression of log2 (FPKM+ 1). The cut-off limit of DEGs was less than 0.05 FDR and greater than 2-fold change
Fig. 6Validation of the DEGs expression exposed to carbendazim using qRT-PCR. Ten genes associated with transmembrane transport (a), response to stress (b), the target gene of carbendazim (c) and oxidoreductase activity (d), were selected for qRT-PCR analysis. (e) Pearson correlation of fold change analyzed between qRT-PCR and RNA-Seq. SJ51_C and SJ51M_C represented without carbendazim treatment, while SJ51_E and SJ51M_E represented exposed to carbendazim treatment. The mRNA abundance was normalized using the housekeeping actin gene, and the gene relative expression levels are represented by the log2Ratio. Data of qRT-PCR are presented as mean ± SD (n = 9)
The major genes modulated in SJ51M and its corresponding wild type strain SJ51 after carbendazim exposure
| Gene ID | Log2 (Fold change) | Gene annotation | |||
|---|---|---|---|---|---|
| SJ51_E vs SJ51_C | SJ51M_E vs SJ51M_C | SJ51M_C vs SJ51_C | SJ51M_E vs SJ51_E | ||
| FVER_05972 | – | 4.0095a | – | 2.2519a | Glyoxalase/Bleomycin resistance pro- tein/Dioxygenase superfamily |
| FVER_12450 | 1.6720a | 3.4288a | 0.1681 | 1.9312a | Glyoxalase/Bleomycin resistance pro- tein/Dioxygenase superfamily |
| FVER_11289 | −0.1793 | − 0.2528 | 1.8589a | 1.7887a | Multidrug resistance protein CDR2 |
| FVER_09237 | −0.6985 | 0.6653 | 1.0074 | 2.2519a | Multidrug resistance protein fnx1 |
| FVER_12798 | −0.3570 | −1.5140a | 0.7393 | −0.4143 | Multidrug resistance protein CDR1 |
| FVER_09560 | 0.0170 | −0.8521 | 2.8984a | 2.0326a | ABC transporter CDR4 |
| FVER_04236 | −0.0264 | − 0.4497 | 1.0549a | 0.6350 | Probable MFS multidrug resistance transporter |
| FVER_10334 | 2.5884a | 1.2424 | 1.3038 | − 0.0260 | Pleiotropic ABC efflux transporter of multiple drugs |
| FVER_03030 | −0.3064 | 0.1645 | 2.6240a | 3.0980a | Related to ATP-binding multidrug cassette transport protein |
| FVER_05891 | 0.0651 | −0.3041 | 1.2302a | 0.8643 | Probable ATP-binding multidrug cassette transport protein |
| FVER_03551 | 0.1228 | 1.1575a | 0.2902 | 1.3278a | ABC transporter ATP-binding protein |
| FVER_11889 | −0.3146 | 0.0465 | 2.5807a | 2.8235a | Caffeine resistance protein 5 |
| FVER_01165 | 2.6628a | 2.3188a | 1.3811 | 1.0704 a | Metal resistance protein YCF1 |
| FVER_03117 | −0.9540 | −0.0568 | 1.4012a | 2.3016 a | Heat shock protein 60, mitochondrial |
| FVER_04661 | −0.7160 | 0.4776 | 1.2237a | 2.4205a | Heat shock protein 78, mitochondrial |
| FVER_04571 | −0.6983 | 0.2399 | 1.1257a | 2.0672a | Probable heat shock protein HSP104 |
| FVER_12593 | −0.3875 | 0.1239 | 0.9569 | 1.4716a | Heat shock protein sti1 homolog |
| FVER_02883 | −0.7821 | 0.3016 | 1.0488a | 2.1358a | Heat shock 70 kDa protein |
| FVER_09674 | 0.0077 | 0.1043 | 0.9416 | 1.0415a | Heat shock 70 kDa protein |
| FVER_01860 | −1.1244a | 0.5785 | 0.9860 | 2.6906a | Probable FES1-Hsp70 nucleotide exchange factor |
| FVER_11673 | −0.9108 | 0.6567 | 0.7528 | 2.3235a | Heat shock 70 kDa protein |
| FVER_10345 | −0.6977 | 0.2154 | 1.1314a | 2.0537a | Heat shock protein 90 |
| FVER_09151 | −1.4554a | 0.1075 | 1.9281a | 3.4943a | Related to heat shock protein 30 |
| FVER_04255 | 0.1770 | −0.5574 | 1.1400a | 0.4186 | Probable chaperone protein HSP31 |
| FVER_08232 | −0.2435 | 0.5509 | −1.0321a | − 0.2344 | Catalase |
| FVER_08876 | −0.1428 | 0.4837 | 1.5837a | 2.2136a | Catalase |
| FVER_11010 | −0.6185 | 0.1034 | 0.9058 | 1.6309a | Thioredoxin |
| FVER_02416 | −0.1779 | 2.1616a | − 0.1494 | 2.1632a | Related to thioredoxin reductase |
| FVER_07248 | −0.6687 | −0.7614 | 1.1560a | 1.0657a | Related to DSBA-like thioredoxin domain protein |
| FVER_13986 | 0.4550 | 1.4076a | 0.3056 | 1.2617a | Related to cytosolic Cu/Zn superoxide dismutase |
| FVER_05859 | 1.2131a | 0.5427 | 1.2630a | 0.5976 | Cytochrome P450 52A3-A |
| FVER_11192 | −0.0087 | 0.0414 | 1.6595a | 1.7130a | Cytochrome P450 52A6 |
| FVER_08550 | 1.0365 | −1.0307 | 2.2312a | 0.1358 | Related to Glutathione S-transferase II |
| FVER_09899 | 0.0960 | −0.2003 | 1.5924a | 1.2997a | Related to microsomal glutathione S-transferase 3 |
| FVER_00097 | −0.4491 | −0.5106 | 1.4609a | 1.4023a | Glutathione S-transferase |
| FVER_09254 | 1.4333a | 0.3586 | 0.2223 | − 0.8490 | Beta-tubulin 2 |
| FVER_09965 | −1.6756a | 0.3958 | −1.3325 | 0.7231 | Probable kinesin-related protein KIP3 |
| FVER_10733 | 3.9528a | 2.0084a | 0.1825 | −1.7512a | Kinesin-like protein KIP3 |
| FVER_05071 | 0.2857 | 1.1278a | − 0.7088 | 0.1354 | Kinesin-like protein klpA |
| FVER_08360 | 0.6639 | 3.7064a | − 1.4850a | 1.5549a | Kinesin family member 1/13/14 |
| FVER_00402 | −0.3106 | 1.6102a | − 0.6439 | 1.2774a | GTP-binding protein rhoC |
aIndicateed significantly differential expression. SJ51_C and SJ51M_C represented without carbendazim treatment, while SJ51_E and SJ51M_E represented exposed to carbendazim treatment. The cut-off limit of DEGs was less than 0.05 FDR and greater than 2-fold change. -, no expression was detected in SJ51_C and the expression abundance was very low in SJ51_E